You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三生製藥(01530.HK)完成向輝瑞配售3114.25萬股 淨籌7.85億港元用於全球研發佈局等
格隆匯 08-01 17:09

格隆匯8月1日丨三生製藥(01530.HK)宣佈,認購事項之所有先決條件已達成,並於2025年8月1日完成。合共3114.25萬股認購股份已按認購價每股認購股份25.2055港元成功發行予輝瑞。認購股份佔(i)緊接認購完成前公司現有已發行股本的約1.30%;及(ii)通過發行及配發認購股份擴大股本規模後的公司已發行股本的約1.28%。

認購事項所得款項總額約爲7.850億港元。扣除相關成本及開支後,認購事項的所得款項淨額合共約7.850億港元。公司擬將(i)約6.280億港元(佔所得款項淨額的80%)用於豐富產品管線中的臨牀及臨牀前項目的全球研發佈局,以及改善生產設施;及(ii)約1.570億港元(佔所得款項淨額的20%)用於其它一般公司用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account